DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 08/28/2026 has been entered.
Response to Arguments
Claim Objection
Applicant's arguments filed 08/28/2026 have been fully considered. Applicant argues that the claim amendment resolves the objection issue and therefore the objection should be withdrawn. In response to the argument and in light of the amendment, the objection is withdrawn.
Rejection Under 101
Applicant's arguments filed 08/28/2026 have been fully considered.
Applicant argues that the amended claims recite a practical application by reciting additional elements that limit the exception to a particular technology and technical outcome. The claim recites an improvement to data-ingestion technology by detecting anomalies to maintain collection and perform self-healing. This improvement is separable from the life assessment asserted in the abstract idea.
In response to the argument, the amended claims recite additional elements that amount to invoking the use of computers/tools to carry out the abstract idea and insignificant extrasolution activity. Thus, the additional elements cannot amount to a practical application. See the updated rejection for further clarification. Additionally, the limitations directed to detecting anomalies and performing self-healing are operational steps that falls under the abstract idea and the technology stack is the additional element to carry out the abstract idea.
Applicant argues that the claims are analogous to Example 47, “Anomaly Detection,” since the claims recite a particular means—cause-and-impact correlation followed by automated, pattern-based self-healing of recurring incidents-- by which the continuity of biodata collection technology stack is preserved. The amended claims recite a technology-rooted solution to a technology-rooted problem: the interruption of a continuous biodata -collection pipeline by recurring transmission anomalies, remediated automatically and without manual intervention.
In response to Applicant’s argument, the claimed invention is directed to a method of a personalized lifespan prediction. The specification at [001]-[009] discusses how sudden and early deaths happen due to a lack of early-stage disease detection, while an inaccurate diagnosis increases risk of death. The prediction system is summarized to assess life expectancy using artificial intelligence. Applicant’s amended claims recite evaluating life expectancy for a person and merely invoke the use of machine learning in order to process data. Additionally, the technology stack is recited at a high level of generality and thus merely invoking the use of a computer. Thus, the claims are unlike Example 47 because they do not recite a particular means for improving the technology. See the updated rejection for further clarification.
Applicant argues that the self-healing operation is a technical function performed on the data-transport layer and improves the operation of the technology. Thus, the exception is integrated into a practical application.
In response to Applicant’s argument, the amended claims fall under organizing human activity, since the claims recite limitations directed toward following rules or instructions to evaluate life expectancy for a person. The limitation directed to detecting the anomalies and self-healing is understood to be an instructional step that is part of the abstract idea to maintain health parameters for assess the life expectancy. Therefore, the limitation is part of the abstract idea.
Applicant argues that the rejection cannot be sustained because it lacks factual support that Berkheimer requires for well-understood, routine, and conventional findings.
In response to Applicant’s argument, the Berkheimer evidence has always been provided in the analysis at Step 2B. See the rejection below for further clarification.
Applicant argues that the authorities cited in the office action are distinguishable since the amended claims recite a specific improvement (Alice and Intellectual Ventures).
In response to Applicant’s argument, the caselaw was not cited to discuss the alleged improvement but rather the caselaw provided was the Berkheimer evidence in the analysis at Step 2B. For example, see MPEP 2106.05 where the Alice caselaw is discussed as being recognized by the courts as support for the generic computer components recited. See the rejection below for further clarification.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Claims 1-12, 14-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., an abstract idea) without significantly more.
Step 1 of the Alice/Mayo Test
Claims 1-11 are drawn to a system, which is within the four statutory categories (i.e. apparatus). Claims 12, 14-20 are drawn to a method, which is within the four statutory categories (i.e. process).
Step 2A of the Alice/Mayo Test - Prong One
The independent claims recite an abstract idea. For example, claim 1 (and substantially similar with independent claim 12) recites:
A prediction system to assess life expectancy and a plurality of health parameter factors, said prediction system comprising:
one or more processors; and
a memory comprising instructions executable by the one or more processors to:
receive (i) online, real-time vital biodata from at least one wearable device sensor or a health data aggregation platform via a communication network, and (ii) offline biodata comprising laboratory results of biomaterial collected using an all-in-one portable biomaterial container and analyzed using a mass spectrometer, wherein the laboratory results are received via the communication network;
store the received biodata in a first database, and form network input data by aligning the received biodata to a stored list of required parameters for permanent tracking of at least one disease, including structuring unstructured medical database data into structured parameter fields corresponding to parameter names of the stored list and matching a user dataset to general-population datasets that use a same parameter list;
monitor said plurality of health parameter factors;
assess a particular health parameter factor of the plurality of health parameter factors using a neural network trained on data retrieved from a first database configured to store said plurality of health parameter factors from a group of individuals, wherein, said data retrieved from said first database is network input data comprising a set of parameters obtained from medical records, wearable devices, questionnaires and network output data of said neural network is a human health factor directly related to life expectancy of at least one individual of the group of individuals;
perform a multi-stage evaluation comprising: (i) instantly evaluating human data associated with the group of individuals obtained at a particular point in time using a training sample comprising a large number of people and summarizing characteristics of people from said training sample; (ii) developing a historical data neural network that analyzes historical data of an individual and a group of individuals with similar parameters, wherein said historical data neural network is trained with a large amount of data over a long period of time; and (iii) recognizing patterns from a plurality of input parameters using personalized network parameter(s) selected from genetic characteristics, current physical condition of a body, blood parameters, nutrition, and psycho emotional state to determine an accurate forecast for said individual;
determine a human health assessment factor from the personalized network parameter(s) and the accurate forecast;
in response to receiving subsequent historical data associated with the individual or detecting a significant change in at least one vital parameter that changes the accurate forecast, modify the historical data neural network and generate an updated human health assessment factor that is directly related to an updated life expectancy of the individual;
generate and transmit to a mobile application of a user device a machine-readable disease risk report and severe disease prevention recommendations based on the updated human health assessment factor; and
detect anomalies in incoming biodata transmissions affecting health and performance of a technology stack, including correlating the detected anomalies to identify a potential cause and an impact of the anomalies on continued collection of the plurality of health parameter factors, and automatically remediate recurring anomalies by performing self-healing through automation for recurring incidents, based on learned patterns of past incidents, to maintain collection of said plurality of health parameter factors without manual intervention.
These underlined elements recite an abstract idea that can be categorized, under its broadest reasonable interpretation, to cover the management of personal behavior or interactions (i.e., following rules or instructions), but for the recitation of generic computer components. For example, but for the prediction system, wearable device, a health data aggregation platform, a communication network, mass spectrometer, database, a trained historical data neural network, mobile app, user device, technology stack, the limitations in the context of this claim encompass an automation of organizing health information in order follow rules or steps to assess and evaluate the life expectancy of an individual and provide a report and prevention recommendations to the individual. If a claim limitation, under its broadest reasonable interpretation, covers management of personal behaviors or interactions but for the recitation of generic computer components, then the limitations fall within the “Certain Methods of Organizing Human Activity” grouping of abstract ideas. See MPEP § 2106.04(a).
Dependent claims recite additional subject matter which further narrows or defines the abstract idea embodied in the claims (such as claims 2-11 and 14-20 reciting particular aspects of the abstract idea).
Step 2A of the Alice/Mayo Test - Prong Two
For example, claim 1 (and substantially similar with independent claim 12) recites:
A prediction system to assess life expectancy and a plurality of health parameter factors, said prediction system comprising: (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f))
one or more processors; and (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f))
a memory comprising instructions executable by the one or more processors to: (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f))
receive (i) online, real-time vital biodata from at least one wearable device sensor or a health data aggregation platform via a communication network, and (ii) offline biodata comprising laboratory results of biomaterial collected using an all-in-one portable biomaterial container and analyzed using a mass spectrometer, wherein the laboratory results are received via the communication network; (merely data-gathering steps as noted below, see MPEP 2106.05(g)) and (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f))
store the received biodata in a first database (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)), and form network input data by aligning the received biodata to a stored list of required parameters for permanent tracking of at least one disease, including structuring unstructured medical database data into structured parameter fields corresponding to parameter names of the stored list and matching a user dataset to general-population datasets that use a same parameter list;
monitor said plurality of health parameter factors;
assess a particular health parameter factor of the plurality of health parameter factors using a neural network trained on data retrieved from a first database (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) configured to store said plurality of health parameter factors from a group of individuals, wherein, said data retrieved from said first database (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) is network input data comprising a set of parameters obtained from medical records, wearable devices (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)), questionnaires and network output data of said neural network is a human health factor directly related to life expectancy of at least one individual of the group of individuals;
perform a multi-stage evaluation comprising: (i) instantly evaluating human data associated with the group of individuals obtained at a particular point in time using a training sample comprising a large number of people and summarizing characteristics of people from said training sample; (ii) developing a historical data neural network that analyzes historical data of an individual and a group of individuals with similar parameters, wherein said historical data neural network is trained with a large amount of data over a long period of time; and (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) (iii) recognizing patterns from a plurality of input parameters using personalized network parameter(s) selected from genetic characteristics, current physical condition of a body, blood parameters, nutrition, and psycho emotional state to determine an accurate forecast for said individual;
determine a human health assessment factor from the personalized network parameter(s) and the accurate forecast;
in response to receiving subsequent historical data associated with the individual or detecting a significant change in at least one vital parameter that changes the accurate forecast, modify the historical data neural network (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) and generate an updated human health assessment factor that is directly related to an updated life expectancy of the individual;
generate and transmit to a mobile application of a user device a machine-readable(merely insignificant extrasolution activity steps as noted below, see MPEP 2106.05(g)) and (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) disease risk report and severe disease prevention recommendations based on the updated human health assessment factor; and
detect anomalies in incoming biodata transmissions affecting health and performance of a technology stack (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)), including correlating the detected anomalies to identify a potential cause and an impact of the anomalies on continued collection of the plurality of health parameter factors, and automatically remediate recurring anomalies by performing self-healing through automation for recurring incidents, based on learned patterns of past incidents, to maintain collection of said plurality of health parameter factors without manual intervention.
The judicial exception is not integrated into a practical application. In particular, the additional elements do not integrate the abstract idea into a practical application, other than the abstract idea per se, because the additional elements amount to no more than limitations, which:
amount to mere instructions to apply an exception (such as recitations of the prediction system, wearable device, a health data aggregation platform, a communication network, mass spectrometer, database, a trained historical data neural network, mobile app, user device, technology stack, thereby invoking computers as a tool to perform the abstract idea, see applicant’s specification [0005]-[0009], [0020], [0036], [0041], [0046], [0056], [0058], [0075], see MPEP 2106.05(f))
add insignificant extra-solution activity to the abstract idea (such as recitation of receiving online sensor data and offline lab data amounts to selecting a particular data source or type of data to be manipulated; transmitting a report and recommendation to an app on a user device amounts to insignificant extrasolution activity, see MPEP 2106.05(g))
Dependent claims recite additional subject matter which amount to limitations consistent with the additional elements in the independent claims (such as claim 2 recites taking into account time periods to train the neural network, which furthers the abstract idea; claim 3, 16 recites the assessment factor is a combination of values obtained from test data of the individual and a group individuals with the same parameters of functional characteristics, which furthers the abstract idea; claim 4, 17 recites the parameter factor is selected from one or in combination from height, weight, etc., which furthers the abstract idea; claim 5 recites the neural network is recurrent or convolutional, which furthers the abstract idea; claim 6, 15 recites to form a core network trained on a large data sample, which furthers the abstract idea; claim 7, 18 recites where using algorithms comprising stochastic gradient descent optimizer, etc., which furthers the abstract idea; claim 8 recites sending requests to the AI engine module and generating a disease risk report, which furthers the abstract idea; claim 9 recites splitting the parameters into offline and online tracking categories, which furthers the abstract idea; claim 10 recites the wearable contains at least one sensor from the list provided, which amounts to invoking computers as a tool to perform the abstract idea; claim 11, 20 recites a list of required parameters, which furthers the abstract idea; claim 14 recites evaluating human data training samples which furthers the abstract idea; claim 19 recites recording physical properties of the individual, which furthers the abstract idea; and claims 2-11 and 14-20 additional limitations which generally link the abstract idea to a particular technological environment or field of use). Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation and do not impose a meaningful limit to integrate the abstract idea into a practical application.
Step 2B of the Alice/Mayo Test for Claims
The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to discussion of integration of the abstract idea into a practical application, the additional elements amount to no more than mere instructions to apply an exception and add insignificant extra-solution activity to the abstract idea. Additionally, the additional elements, other than the abstract idea per se, amount to no more than elements which:
amount to elements that have been recognized as well-understood, routine, and conventional activity in particular fields (such as using the prediction system, wearable device, a health data aggregation platform, a communication network, mass spectrometer, database, a trained historical data neural network, mobile app, user device, technology stack, e.g., Applicant’s spec describes the computer system with it being well-understood, routine, and conventional because it describes in a manner that the additional elements are sufficiently well-known that the specification does not need to describe the particulars of such elements to satisfy 112a. (See Applicant’s Spec. [0005]-[0009], [0020], [0036], [0041], [0046], [0056], [0058], [0075]); using a processor to perform the instructions, prediction system, a health data aggregation platform, a communication network, database, a trained historical data neural network, mobile app, user device, technology stack, e.g., merely adding a generic computer, generic computer components, or a programmed computer to perform generic computer functions, Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347, 2358-59, 110 USPQ2d 1976, 1983-84 (2014).
adding insignificant extrasolution activity to the abstract idea, for example mere data gathering, selecting a particular data source or type of data to be manipulated, and/or insignificant application. The following represent examples that courts have identified as insignificant extrasolution activities (e.g. see MPEP 2106.05(g)): receiving online sensor data and offline lab data, e.g., using the Internet to gather data, Symantec, 838 F.3d at 1321 and MPEP 2106.05(g)(3); transmitting a report and recommendation to an app on a user device, e.g., outputting or providing access to the information, Symantec, 838 F.3d at 1321 and MPEP 2106.05(g)(3)).
Dependent claims recite additional subject matter which, as discussed above with respect to integration of the abstract idea into a practical application, amount to invoking computers as a tool to perform the abstract idea, and are generally linking the abstract idea to a particular field of environment. Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. Therefore, the claims are not patent eligible, and are rejected under 35 U.S.C. § 101.
Subject Matter Free of Prior Art
Claims 1-12, 14-20 are free of prior art over Klibanow (US 2010/0324943) in view of Jiao (US 2016/0140310), Lore (US 20180107662). The prior art references, or reasonable combination thereof, could not be found to disclose, or suggest all of the limitations found in the independent claims. The closest prior art is Klibanow (US 2010/0324943), which teaches evaluating a life expectancy. Jiao (US 2016/0140310) teaches predicting health outcomes using trained machine learning models. Lore (US 20180107662) teaches wearable sensors to monitor and obtain human data. The references, or reasonable combination thereof, could not be found to disclose, or suggest all of the limitations found in the independent claims.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMANDA R COVINGTON whose telephone number is (303)297-4604. The examiner can normally be reached Monday - Friday, 10 - 5 MT.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason B. Dunham can be reached on (571) 272-8109. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/AMANDA R. COVINGTON/Examiner, Art Unit 3686
/RACHELLE L REICHERT/Primary Examiner, Art Unit 3686